- ÀÏ ½Ã
- 2020³â 7¿ù 17ÀÏ(±Ý) - 18ÀÏ(Åä)
- Àå ¼Ò
- ±¤ÁÖ ¶ó¸¶´ÙÇöóÀÚÈ£ÅÚ
- »çÀüµî·Ï ±â°£
- 2020³â 2¿ù 17ÀÏ(¿ù) ~ 7¿ù 6ÀÏ(¿ù)±îÁö
- µî ·Ï ºñ
- »çÀüµî·Ï - Àü¹®ÀÇ 50,000¿ø, Àü°øÀÇ/°£È£»ç ¹× ±âŸ 30,000¿ø
ÇöÀåµî·Ï - Àü¹®ÀÇ 60,000¿ø, Àü°øÀÇ/°£È£»ç ¹× ±âŸ 40,000¿ø
- °èÁ¹øÈ£
- KEBÇϳªÀºÇà 501-910052-96405 (¿¹±ÝÁÖ : ´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ)
ÇÁ·Î±×·¥
7¿ù 17ÀÏ(±Ý¿äÀÏ) | ||
---|---|---|
12:30 - 13:30 | ÆòÀÇ¿øȸ | |
13:30 - 13:50 | µî·Ï | |
13:50 - 14:00 | ȸÀå´Ô, ÀÌ»çÀå´Ô Àλç | |
14:00 - 16:00 | Scientific Session I : Biologic Therapy for Pediatric Cancer | |
14:00 - 14:30 | Immune checkpoint blockade therapy in children | ÇÑÁ¤¿ì (¿¬¼¼ÀÇ´ë) |
14:30 - 15:00 | TKI in therapy in solid tumor | ÃÖÁ¤À± (¼¿ïÀÇ´ë) |
15:00 - 15:40 | TKI therapy in hematologic malignancy | Michel Zwaan (Princess Maxima Center for Pediatric Oncology, Germany) |
15:40 - 16:00 | Coffee Break | |
16:00 - 17:10 | Scientific Session II : Veno-Occlusive Disease (VOD) | |
16:00 - 16:30 | Chemotherapy induced VOD | ¾çÀ¯Áø (ºÎ»êÀÇ´ë) |
16:30 - 17:10 | VOD after HSCT | Krzysztof Kalwak (Wroclaw Medical University, Poland) |
17:10 - 18:00 | Case Discussion Session | °í°æ³² (¿ï»êÀÇ´ë) |
7¿ù 18ÀÏ(Åä¿äÀÏ) | ||
---|---|---|
09:00 - 10:00 | K-PHOG Session / °£È£»ç Session | ¡¡ |
10:00 - 10:20 | Coffee Break | |
10:20 - 11:00 | Special Lecture | |
10:20 - 11:00 | Medical system for pediatric cancer in Netherlands | Michel Zwaan (Princess Maxima Center for Pediatric Oncology, Germany) |
11:00 - 12:00 | Scientific Session III : Cancer Predisposing Syndrome | |
11:00 - 11:30 | Overview of cancer predisposing syndrome | ÀÌÁö¿ø (¼º±Õ°üÀÇ´ë) |
11:30 - 12:00 | Multidisciplinary approach for NF1 | ±èÇý¸® (¿ï»êÀÇ´ë) |
12:00 | Æóȸ |